This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
4 - 6 June, 2024
Excel London Platinum Suite

Milos Aleksic, Ph.D.
Senior Director, Drug Discovery at Immunocore Limited


Milos Aleksic joined Immunocore in 2010 and currently is leading Drug Discovery department responsible for engineering T cell receptor (TCR) based soluble bispecific ImmTAX molecules for targeting cancer, autoimmune and infection diseases. The main responsibility of the department is discovery of specific wt TCRs, their affinity engineering and production as high affinity bispecific molecules that modulate immune response. Prior to this role, Milos was a postgraduate researcher at University of Oxford where he studied molecular interaction between TCR and pHLA molecules.

Agenda Sessions

  • Developing ImmTAC Against PIWIL1, A Promising Novel Colorectal Cancer Target